Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus

NCT01974518 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
20
Enrollment
UNKNOWN
Sponsor class

Conditions

Interventions

Sponsor

Uprety Shraddha

Collaborators